The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krebs, P.
Right arrow Articles by Ludewig, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krebs, P.
Right arrow Articles by Ludewig, B.
The Journal of Immunology, 2005, 174: 4559-4566.
Copyright © 2005 by The American Association of Immunologists

Rapid Functional Exhaustion and Deletion of CTL following Immunization with Recombinant Adenovirus1

Philippe Krebs*,{dagger}, Elke Scandella*, Bernhard Odermatt{ddagger} and Burkhard Ludewig2,*

* Research Department, Kantonal Hospital St. Gallen, St. Gallen, Switzerland; and {dagger} Institute of Experimental Immunology and {ddagger} Department of Pathology, University Hospital Zürich, Zürich, Switzerland

Replication-deficient adenoviruses (recombinant adenovirus (rec-AdV)) expressing different transgenes are widely used vectors for gene therapy and vaccination. In this study, we describe the tolerization of transgene-specific CTL following administration of {beta}-galactosidase ({beta}gal)-recombinant adenovirus (Ad-LacZ). Using MHC class I tetramers to track {beta}gal-specific CTL, we found that a significant expansion of {beta}gal-specific CTL was restricted to a very narrow dose range. Functional analysis revealed that adenovirus-induced {beta}gal-specific CTL produced only very low amounts of effector cytokines and were unable to exhibit cytolytic activity in a 51Cr release assay. Furthermore, Ad-LacZ vaccination failed to efficiently clear established {beta}gal-positive tumors. The impaired function of Ad-LacZ-induced CTL correlated with the presence of persisting {beta}gal Ag in the liver. A further increase in the peripheral Ag load by injection of Ad-LacZ into SM-LacZ transgenic mice which express {beta}gal as self-Ag exclusively in peripheral nonlymphoid organs, resulted in the physical deletion of {beta}gal-specific CTL. Our results indicate first that CTL deletion in the course of adenoviral vaccination is preceded by their functional impairment and second, that the outcome of rec-AdV vaccination depends critically on the Ag load in peripheral tissues.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. R. Lukens, M. W. Cruise, M. G. Lassen, and Y. S. Hahn
Blockade of PD-1/B7-H1 Interaction Restores Effector CD8+ T Cell Responses in a Hepatitis C Virus Core Murine Model
J. Immunol., April 1, 2008; 180(7): 4875 - 4884.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. M. Laughlin, J. D. Miller, E. James, D. Fillos, C. C. Ibegbu, R. S. Mittler, R. Akondy, W. Kwok, R. Ahmed, and G. Nepom
Antigen-Specific CD4+ T Cells Recognize Epitopes of Protective Antigen following Vaccination with an Anthrax Vaccine
Infect. Immun., April 1, 2007; 75(4): 1852 - 1860.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T.-C. Yang, J. Millar, T. Groves, N. Grinshtein, R. Parsons, S. Takenaka, Y. Wan, and J. L. Bramson
The CD8+ T Cell Population Elicited by Recombinant Adenovirus Displays a Novel Partially Exhausted Phenotype Associated with Prolonged Antigen Presentation That Nonetheless Provides Long-Term Immunity
J. Immunol., January 1, 2006; 176(1): 200 - 210.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.